Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hip Viscosupplementation Dosage Study
NCT01810809Phase 4Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Apr 2013
- Primary completion
- Jun 2014
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of hylan gf-20 in osteoarthritis (OA) (4 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Western Ontario and McMaster Universities Index at 6 months, Visual Analogic Scale of Pain at 6 months and 1 more. Status: unknown.
02
Drugs
hylan gf-20
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01810809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01810809.